Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis; D000917:Antibody Formation; D000961:Antilymphocyte Serum; D001500:BCG Vaccine / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D003168:Complement Fixation Tests; D005455:Fluorescent Antibody Technique; D006084:Graft Rejection; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D008212:Lymphocyte Depletion; D008297:Male; D009163:Mycobacterium bovis / Q000276:immunology*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D014184:Transplantation, Homologous
D000912:Antibodies, Neoplasm; D000961:Antilymphocyte Serum; D001500:BCG Vaccine